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Background: Information on the community-based prevalence of tuberculosis (TB) in different
settings is vital for planning, execution and evaluation of strategies to control the disease.
Objective: To assess community-based prevalence of undetected active pulmonary TB (PTB) in
pastoralists of the Amibara District.
Methods: BetweenMarch and April 2010, a community-based cross-sectional survey of undiag-
nosed active PTB was conducted in the pastoralists of the Amibara District of the Afar Region,
north-east Ethiopia. The study participants were interviewed for symptoms suggestive of PTB
using a structured questionnaire. Sputum samples were collected and processed for smear
microscopy and culture. Mycobacterium genus typing was performed using a multiplex poly-
merase chain reaction (PCR).
Results: Out of 222 individuals who had symptoms suggestive of PTB, 4 (1.8%) were found posi-
tive by smear microscopy, while mycobacterial growth was observed on 62 (27.9%) samples.
Mycobacterium genus typing was carried out for 42 of these 62 samples; 39 (92.9%) gave a posi-
tive signal for the genusMycobacterium. Of these, 23 (59%) isolates proved to be members of the
Mycobacterium tuberculosis (Mtb) complex, while the remaining 16 (41.0%) were found to be
members of non-tuberculous Mycobacteria (NTM) species.
Conclusion: Sputum culture is highly sensitive, and it is the gold standard for the bacteriological
diagnosis of PTB, while smear microscopy is less sensitive to detect acid fast bacilli (AFB) in
stained sputum smears. The findings of the present study warrant the strengthening of culture
facility services in the study area. The study also provides important preliminary information on
the status of NTM infection in the pastoral setting. Nevertheless, further investigations into the
species identification of the NTM infections would be useful in the study area.
 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction and mortality in the sub-Saharan African and SoutheastAlthough TB is known to be an ancient human disease, it has
come to the forefront as one of the major causes of morbidity-African Society for Myco
ma Institute of Pathobio
. Legesse).Asian countries since the mid-1980s mainly owing to the Hu-
man Immunodeficiency Virus (HIV) pandemic [1]. In 1993, the
World Health Organization (WHO) declared TB to be a globalbacteriology. Published by Elsevier Ltd. All rights reserved.
logy, Addis Ababa University, Addis Ababa, P.O. Box 1176, Ethiopia.
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the next decade unless immediate action was taken to control
its spread. Consequently, directly observed treatment short
course (DOTS) has been the internationally recommended
strategy to combat TB globally [1]. Although the DOTS strat-
egy is crucial for the control of TB, many community-based
surveys of active PTB have revealed the existence of consider-
able numbers of undiagnosed individuals who would contrib-
ute to the transmission of the disease [2–7] indicating that the
DOTS strategy alone will not be sufficient to achieve the tar-
geted reduction in the global incidence rate by 2015 unless
it is supported by active case detection.
Moreover, in most developing countries, the DOTS strategy
uses smear microscopy for case detection, which is less sen-
sitive than the culture method. Hence, a considerable number
of PTB cases who can transmit the disease remain undiag-
nosed and untreated [6,8]. Similarly, diagnostic and treatment
delay due to patient-associated reasons [9–12], especially a
lack of knowledge of the early symptoms of TB (coughing),
unless accompanied by other severe symptoms (like chest
pain or hemoptysis) [13], could have a significant impact on
the success of the TB control strategies.
Numerous studies in both developed and developing coun-
tries have shown that infection with NTM causes significant
health problems in both HIV-infected and non-infected indi-
viduals [14–23]. However, in developing countries, where
there are limited resources and laboratory facilities for the
identification of NTM, infection with NTM can be misdiag-
nosed as infection with Mtb complex [22,24].
Ethiopia is among the 22 countries in the world with a high
TB burden [25]. TB is one of the major public health problems
among the Afar pastoralists [26]. However, the prevalence of
undiagnosed active TB in the Afar pastoral communities is
unknown. In this study, the community-based prevalence of
undiagnosed active PTB and NTM infections in pastoralists
in the Amibara District, Afar Region, was assessed using a
questionnaire, sputum smear microscopy, sputum culture
and Mycobacterium genus typing.
Materials and methods
Study area and study population
A household-based cross-sectional survey of undiagnosed ac-
tive PTB was conducted in the Amibara district, north-east
Ethiopia, between March and April 2010. The region has a to-
tal population of 1,411,092, with an estimated area of 96,707
square kilometers [27]. The Amibara District is located in
the Middle Awash valley, about 260 km to the north-east of
Addis Ababa. The district has 18 kebeles (small administrative
units), of which 4 are semi-towns, while the rest are pastoral
kebeles. Detailed information on the study areas and the
study population has been described elsewhere [28].
The aim was to include all 14 pastoral kebeles of the dis-
trict in this survey. However, one kebele, which has a total
population of 2331 (of whom 1231 are over 15 years of age),
was not included because of financial constraints; hence, 13
kebeles with a total population of 34,428, of whom 18,192
(52.84%) were P15 years of age were included in this study.
The excluded kebele is situated on the main road to Djibouti,and there is a small town in that kebele of which about half of
the residents are not pastoralists.Data collection
A house-to-house survey of all households in the 13 kebeles
of the district was conducted by trained community health
workers under the supervision of the principal investigator.
Although clinical symptoms are not the ultimate methods
for screening for PTB in TB endemic settings [6,29], standard-
ized questionnaires were used for screening symptoms sug-
gestive of PTB [30].
After the aim of the survey had been explained, the heads
of the households (husband or wife) or individuals aged over
18 years were asked if there was any family member (age
P15 years) who had suffered from coughing for at least two
weeks, expectoration, haemoptysis, chest pain, night sweats,
breathlessness, loss of appetite/weight or fever. Individuals
who had coughed for at least two weeks, with or without
other symptoms, were interviewed using the structured ques-
tionnaire for common signs/symptoms of PTB, onset of ill-
ness, treatment sought, past history of TB, and contact with
PTB patients. The respondent was also asked whether he/
she suspected his/her illness was TB. In the case of children
younger than 18 years, the head of the household or other
household members were interviewed. Information on so-
cio-demographic characteristics of the individuals was also
included in the questionnaire.Sputum collection and examination
Following the interview, each individual suspected of PTB was
instructed on how to expectorate a sputum sample. A coded
sputum cup was then provided, and the individual was re-
quested to submit the first on-the-spot sputum sample. After
providing the first sample, the individual was given a new
sputum cup and instructed to provide an early morning spu-
tum sample. A third sputum sample was collected on the sec-
ond day, when the individual submitted the early morning
sputum sample.
Each sputum sample was transported to the main district
health center (Melka Werer Health Centre) on the day of col-
lection. At the health center, a direct smear was prepared
from each specimen, processed using the Ziehl-Neelsen
(ZN) staining technique, and microscopically examined for
acid-fast bacillus (AFB) by two experienced technicians. A
minimum of 100 oil immersion fields were examined before
a negative result was declared. Positivity was confirmedwhen
at least two out of the three smear results were positive for
AFB [31].
The remainder of each specimen was stored at 4 C pend-
ing transport to the Aklilu Lemma Institute of Pathobiology
(ALIPB) TB laboratory under refrigeration. Upon reaching the
laboratory, specimens from the same individual were pooled
together, processed for culture as previously described [32]
and incubated for eight weeks at 37 C. Cultures were fol-
lowed weekly for the growth of mycobacterial colonies, and
positivity for AFB was confirmed by microscopy. The AFB po-
sitive colonies were collected, heat-killed in a water bath at
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analysis.
Mycobacterial genus typing
The multiplex PCR method was used to differentiate the Mtb
complex from the other mycobacteria [33,34]. Heat-killed col-
onies were used as a source of template DNA. DNAwas ampli-
fied in a thermocycler in 20 ll reaction volumes consisting of:
5 ll of genomic DNA as a template, 8 ll HotstarTaqMasterMix
(MgCl2, dNTPs, Taq polymerase and PCR buffer) (Qiagen, Uni-
ted Kingdom), 0.3 ll of each of forward and reverse primers
and 5.2 ll of Qiagen water. The primers used for amplification
were MYCGEN-F, 5 0-AGA GTT TGATCC TGG CTC AG-3 0 (35 ng/
ll); MYCGEN-R, 5 0-TGC ACA CAG GCC ACA AGG GA-3 0 (35 ng/
ll); MYCAV-R, 5 0-ACC AGA AGA CAT GCG TCT TG-3 0 (35 ng/
ll); MYCINT-F, 5 0CCT TTA GGC GCA TGA TGT CTT TA-3 0
(75 ng/ll); TB1-F, 5 0-GAA CAA TCC GGA GTT GAC AA-3 0
(20 ng/ll); TB-1-R, 5 0-AGC ACG CTG TCA ATC ATG TA-3 0
(20 ng/ll). M. tuberculosis strains (H37Rv) and M. avium were
used as positive controls, while Qiagen water was used as a
negative control. The reaction mixture was then heated in a
Programme Thermal Controller (Applied Biosystems; PTC-
100TM) using the following amplification program: 95 C for
10 min for enzyme activation; 95 C for 1 min for denatur-
ation; 61 C for 0.5 min for annealing; 72 C for 2 min for
extension, 35 cycles in total, then a final extension step at
72 C for 10 min. The products were electrophoresed and
members of the genus Mycobacterium and Mtb complex were
identified as previously described [33,34].
Treatment and follow-up
Of the study participants who were positive by culture/smear
microscopy, one male died before starting anti-TB treatment,
one male moved to another area, one female was pregnant
and did not volunteer to start the treatment, and five females
did not volunteer to start the treatment because they reported
that they got relief as a result of the antibiotic treatment pro-
vided during sample collection. The remaining participants
started anti-TB treatment at Meleka Werer Health Centre.
HIV testing was performed during anti-TB treatment as per
the national TB and HIV guidelines of Ethiopia [31].
Eight months after the initial survey, the individuals were
re-interviewed for common signs/symptoms of PTB and com-
pletion of the treatment. Individuals who still complained of a
productive cough and other symptoms of PTB after anti-TB
treatment were requested to provide sputum samples, follow-
ing the procedures used during the initial survey. The sputum
samples were processed for smear microscopy and culture as
in the case of the initial survey.
Ethical consideration
The study protocol was approved by the Ethical Clearance
Committee of the ALIPB, Addis Ababa University, and the Re-
gional Committee for Medical Research Ethics of Southern
Norway. The aim of the study was explained to the study par-
ticipants in their own local language, and informed written
consent was obtained from each individual.Data analysis
The collected data were entered into EpiData software, V.3.1.
The data were transferred to StataSE 11 and analyzed accord-
ing to the different variables. The Pearson chi-square test was
used to compare proportions. Univariable and multivariable
logistic regressions were used to explore independent vari-
ables associated with the prevalence of the disease. Results
were considered significant when the P-value was less than
5%.Results
Socio-demographic characteristics of the study participants
Of the 18,192 study population (age P15 years), 222 (1.2%)
were suspected of PTB on the basis of symptoms. Of these
222 individuals, 130 (58.6%) were females, 199 (89.6%) were
pastoralists, and 205 (92.3%) were illiterate. The age range
was 15–88 years, with a median of 40 years. Out of the 54 indi-
viduals who were screened for HIV-infection during anti-TB
treatment, only 1 (1.9%) female was found to be seropositive
for HIV infection. The socio-demographic characteristics of
these 222 study participants are summarized in Table 1. All
households in the selected pastoral kebeles were visited and
none of the visited households or the PTB suspected individ-
uals refused to participate in the study.Smear and culture results
Of the 222 PTB-suspected individuals, 4 (1.8%) (2 women and 2
men) were smear-positive for AFB by microscopy. Three of
these individuals were new smear-positive PTB cases, while
1 had a previous history of treatment for PTB. Thus, the prev-
alence of undiagnosed smear-positive PTB cases in the stud-
ied population was 22 per 100,000. Mycobacterium growth
was observed on 62 (27.9%) sputum samples, including the 4
samples which were positive by microscopy. Hence, the prev-
alence of culture-positive mycobacterial cases was 340 per
100,000 population.
A higher proportion of culture-positive cases was observed
in the 21–35 year age group (v2 = 8.19, P = 0.042) and among
participants who lived more than 40 km from the two health
centers (v2 = 19.68, P = 0.001). Table 1 shows the proportion of
culture-positive cases stratified by the socio-demographic
characteristics of the study participants. The results of uni-
variable logistic regression analysis (Table 1) also showed that
study participants in the 21–35 year age group had 2.98 times
higher odds of being culture-positive for mycobacterial infec-
tion than those between 15 and 20 years of age (crude
OR = 2.98; 95% CI, 1.03–8.64, P = 0.044). Similarly, study partic-
ipants who lived in areas at least 40 km away from the district
health centers had 2.53 times higher odds of being culture-po-
sitive than participants who lived within 10 km of the health
centers (Crude OR = 2.53; 95% CI, 1.03–6.23, P = 0.043). In mul-
tivariable logistic regression analysis, none of the covariates
included in the analysis were significantly associated with
culture positivity.
Table 1 – The proportion and association of culture positivity with socio-demographic characteristics of the study
participants.
Characteristic Study participants
Number (%)
Culture positive
Number (%)
Culture negative
Number (%)
Crude OR (95%CI) Adjusted OR (95%CI)
Gender
Female 130 (58.6) 38 (29.2) 92 (70.8) Reference Reference
Male 92 (41.4) 24 (26.1) 68 (73.9) 1.17 (0.64 – 2.13) 1.15 (0.55–2.38)
Age (year)
15–20 29 (13.1) 6 (20.7) 23 (79.3) Reference Reference
21–35 48 (21.6) 21 (43.8)a 27 (56.3) 2.98 (1.03–8.64) 4.92 (0.91–26.60)
36–45 51 (23.0) 14 (27.5) 37 (72.6) 1.45 (0.49–4.31) 2.28 (0.38–13.88)
46+ 94 (42.3) 21 (22.3) 73 (77.7) 1.10 (0.39 – 3.06) 1.91(0.29–12.47)
Marital status
Married 124 (55.8) 35 (28.2) 89 (71.8) Reference Reference
Single 35 (15.8) 11 (31.4) 24 (68.6) 1.17 (0.52–2.64) 2.13 (0.45–10.02)
Other 63 (28.4) 16 (25.4) 47 (74.6) 0.87 (0.43–1.73) 1.19 (0.51–2.82)
Occupation
Pastoralist 199 (89.6) 58 (29.2) 141(70.9) Reference Reference
Other 23 (10.4) 4 (17.4) 19 (82.6) 0.51 (0.17–1.57) 0.46 (0.13–1.62)
Family size
1–5 100 (45.3) 27 (27.0) 73 (73.0) Reference Reference
6+ 121 (54.7) 35 (28.9) 86 (71.1) 1.10 (0.61–1.99) 1.30 (0.65–2.61)
Distance (km)
<10 41 (18.5) 12 (29.3) 29 (70.7) Reference Reference
10–20 75 (33.8) 10 (13.3) 65 (86.7) 0.37 (0.14–0.96) 0.38 (0.14–1.03)
21–30 34 (15.3) 9 (26.5) 25 (73.5) 0.87 (0.31–2.40) 0.92 (0.31–2.68)
31–40 29 (13.1) 9 (31.0) 20 (69.0) 1.09 (0.39–3.06) 1.09 (0.36–3.35)
>40 43 (19.4) 22 (51.2)a 21 (48.8) 2.53 (1.03–6.23) 2.22 (0.86–5.74)
Past history of TB
Yes 31 (14.0) 12 (38.7) 19 (61.3) Reference Reference
No 191 (86.0) 50 (26.2) 141 (73.8) 0.56 (0.25–1.22) 0.45 (0.18–1.11)
History of contact
Yes 32 (14.5) 9 (28.1) 23 (71.9) Reference Reference
No 190 (85.5) 53 (27.9) 137 (72.1) 0.99 (0.43–2.27) 1.34 (0.49–3.63)
COR, crude odd ratio.
AOR, adjusted odd ratio.
a The proportion was significantly higher (P < 0.05).
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Owing to a constraint on reagents, Mycobacterium genus typ-
ing was conducted on 42 (27 female and 15 male) isolates
from the 62 culture positive isolates. There were no statisti-
cally significant differences in terms of age, gender and symp-
toms of PTB between the 20 subjects who had no PCR results
and the 42 who had PCR results. On the basis of the multiplex
PCR results, 39 (92.9%) isolates revealed the presence of the
genus Mycobacterium, and 23 (59%) of these showed the pres-
ence of Mtb complex species. The remaining 16 (41.0%) iso-
lates were considered as NTM complex. Two samples that
were culture-positive and one that was both culture- and
AFB-positive were negative by multiplex PCR. There was no
statistically significant difference between the proportion of
males and females either with Mtb complex (66.7% versus
48.2%; Fisher’s exact test = 0.678), or with NTM (26.7% versus
44.4%, Fisher’s exact test = 0.555). There was no statistically
significant difference between the proportion of theMtb com-
plex and NTM infections across the various age categories(Fisher’s exact test = 0.744). The proportion of infection with
the Mtb complex and NTM showed no statistically significant
difference based on a previous history of TB (Fisher’s exact
test = 0.288).
Duration of symptoms and treatment sought by the study
participants
Of the 222 study participants who were interviewed, the
majority complained of more than one symptom of PTB; most
frequently coughing and sputum production (98.7%). Chest
pain, night sweats, loss of appetite, breathing problems and
sputum with blood were reported by 203 (91.4%), 173
(77.9%), 179 (80.6%), 177 (79.7%) and 22 (9.9%), respectively.
The duration of the cough reported by the participants
ranged between 2 and 572 weeks, with a median duration of
52 weeks. The majority (71.1%) reported the duration of
coughing of less than one year. Four individuals could not
remember the exact duration of their cough. The proportion
of culture positivity was higher among individuals who re-
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those who reported coughing for more than one year [38/62
(61.3%) versus 24/62 (38.7%), v2 = 4.058, P = 0.044]. A total of
62 (28.6%) individuals suspected their or their families’ dis-
ease was TB (Table 2). A higher proportion of males suspected
the disease than females (38.2% versus 21.9%, v2 = 6.86,
P = 0.009). Among the 30 study participants who had a previ-
ous history of PTB, 23 (76.7%) suspected their or their families’
disease was TB, whereas among the 187 study participants
without a previous history of TB, only 39 (20.9%) suspected
their or their families’ disease as TB (v2 = 39.46, P < 0.00).
Of the 222 participants, 159 (71.6%) reported that they
sought treatment at various health facilities for their or their
families’ illness. The most frequently visited health facilities
were government health centers (47.8%), a private clinic
(39.0%), hospital (13.2%); and health post (9.4%). Others (11/
159, 6.9%) reported that they visited a private pharmacy, drug
vendor or traditional healer.
Among those 148 individuals who visited health facilities
such as a health center, hospital or private clinic, 40 (27%), 2
(1.4%) and 11 (7.4%) reported that they were examined for
PTB by sputum smear microscopy, sputum culture, and chest
radiography, respectively, while the rest reported clinical
examination. Regarding the results of their laboratory or clin-
ical investigations, 89 (56%), 31 (19.5%) and 4 (2.5%) were told
that they had pneumonia, a cold, and asthma, respectively,
and were treated with various drugs. The remaining partici-
pants reported that they were treated for other diseases such
as malaria.
The remaining 63 (28.4%) individuals reported that they
did not seek treatment. The main reason for not visiting
any health facility was lack of money (Table 2). Among the
27 participants who had a past history of TB, 15 (55.6%) knew
that the anti-TB drug is free of charge, while among the 183Table 2 – Reasons for not visiting health facility by the study pa
Variables No
Do you suspect that your/your family disease as TB?
Yes 62
No 15
Duration of cough
6One year 15
>One year 63
Did you seek any treatment?
Yes 15
No 63
Reason for not visiting health facility (n = 74)
Lack of money 52
Distance from health facility 6 (
The illness was not severe 8 (
Work load 5 (
Lack of friends/assistance 11
Lack of effective diagnosis at the nearest health facility 3 (
Do you know that anti-TB drugs are free?
Yes 29
No 18
a The proportion was significantly higher (P < 0.05).individuals without a previous history of TB, only 14 (7.7%)
knew this (v2 = 45.4, P < 0.001).
Results of post-treatment survey
Of the 54 patients who were put on anti-TB treatment, 1 fe-
male (TB-HIV co-infected) and 2 males died after starting
treatment, and 10 individuals (2 males and 8 females) were
lost to follow-up because of migration to other areas within
the region or abroad (Djibouti). Of the remaining 41 subjects
(17 males and 24 females) who were available during the sur-
vey, 18 had Mtb complex infection, 13 had NTM infection, 3
had PCR negative results, and 7 had no PCR results. Of these
41 subjects, 6 (14.6%) reported that they had completed the
treatment; of those 6, 2 had Mtb complex infections, 3 had
NTM infections, and 1 was among those three subjects who
had positive culture results but negative PCR results. A total
of 19 (46.3%) subjects reported that they were on treatment.
Among these 19 subjects, 8 had Mtb complex infections, 6
had NTM infections, and 1 was among those three subjects
who had a positive culture result but negative PCR result,
while 4 were among those who had no PCR results. Among
the 41 subjects, 23 (56.1%) reported that they had interrupted
their treatment because of various reasons (Table 3). Of these
23 individuals who had interrupted their treatment, 9 hadMtb
complex infections, 10 had NTM infections, 1 had a PCR neg-
ative result, and 3 had no PCR results but did have a positive
culture. Among these 23 individuals, 7 re-started the treat-
ment and were among the 19 subjects who were on the treat-
ment, while 16 (69.6%) did not restart the treatment. Of those
16, 8 hadMtb complex infections, 4 had NTM infections, 1 had
a PCR negative result, and 3 had no PCR results.
When those subjects who were lost to follow-up were in-
cluded in the analysis, the proportion of individuals whorticipants.
(%) Male (%) Female (%) Culture
positive,
no (%)
Culture
negative,
no (%)
(28.6) 34 (38.2)a 28 (21.9) 20 (33.3) 42 (26.6)
5 (71.4) 55 (61.8) 100 (78.1)) 40 (66.7) 115 (73.3%)
5 (71.1) 64 (70.3) 91 (71.7) 38 (24.5) 117 (75.5)
(28.9) 27 (29.7) 36 (28.4) 24 (38.7) 39 (61.9)
9 (71.6) 69 (75.0) 90 (69.2) 42 (26.4) 117 (73.6)
(28.4) 23 (25.0) 40 (30.8) 20 (31.6) 43 (68.3)
(70.3) 18 (34.6) 34 (65.4) 15 (28.9) 37 (71.1)
8.1) 1(16.7) 5 (83.3) 3 (50.0) 3 (50.0)
10.8) 3 (37.5) 5 (62.5) 4 (50.0) 4 (50.0)
6.8) 3 (60) 2 (40) 1 (20.0) 4 (80.0)
(14.9) 3 (27.3) 8 (72.7) 3 (27.3) 8 (72.7)
4.1) 0 3 (100) 0 3 (100.0)
(13.8) 15 (17.7) 14 (11.2) 8 (27.6) 21 (72.4)
1 (86.2) 70 (82.4) 111 (88.8) 50 (27.6) 131 (72.4)
Table 3 – Shows study participants who completed treatment, who were on the treatment, who
interrupted the treatment and reasons for interrupting/discontinuing the treatment (n = 41).
Variable Male, No (%) Female, No (%) Total (%)
Treatment completed
Yes 1 (5.9) 5 (20.8) 6(14.6)
No 16 (94.1) 19 (79.2) 35 (85.4)
On treatment (n = 35)
Yes 8 (50) 11(57.9) 19 (54.3)
No 8 (50) 8 (42.1) 16 (45.7)
Period of time on treatment
61 month 1 (5.9) 3 (12.5) 4 (9.8)
2–4 months 7 (41.2) 7 (29.2) 14 (34.2)
5–7 months 8 (47.1) 9 (37.5) 17 (41.5)
8 months 1 (5.9) 5 (20.8) 6 (14.6)
Treatment interrupted
Yes 10 (58.8) 13 (54.2) 23 (56.1)
No 7 (41.2) 11 (45.8) 18 (43.9)
Reason (s) for interrupted treatment (n = 23)
Lack of improvement 0 (0) 1 (7.7) 1 (4.4)
Side effect of the drug 3 (30) 4 (30.8) 7 (30.4)
Relief 8 (80) 1 (7.7) 9 (39.1)
Distance from health center 2 (20) 2 (15.4) 4 (17.4)
Work load 2 (20) 1 (7.7) 3 (13.0)
Migration 2 (20) 0 (0) 2 (8.7)
Other (family death, other disease, pregnancy) 2 (20) 5 (38.5) 7 (30.4)
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 2 ( 2 0 1 3 ) 9 4 –1 0 2 99interrupted their treatment (including those seven individu-
als who interrupted and re-started) was increased to 64.7%
(33/51). There was no statistically significant difference be-
tween the proportion of males and females who interrupted
the treatment (63.2% versus 65.6%, Fisher’s exact test = 0.546).
There was no statistically significant difference between the
proportion of treatment interruption in individuals with
infection by Mtb complex or with NTM (45% versus 50%, Fish-
er’s exact test = 0.362).
Of the 41 individuals who were re-interviewed during the
post-treatment survey, 30 (73.2%) reported a cough together
with other symptoms, such as sputum production, chest
pain, night sweats, breathing problems, and a loss of appetite.
Of these 30 subjects, 10 were among those who hadMtb com-
plex infections, 13 had NTM infections, and 3 had PCR nega-
tive results but positive culture results, while 4 were among
those 20 subjects who had no PCR results. Of the 13 subjects
who had NTM infections and complained of symptoms of
PTB, 3 were among those who had completed the treatment.
Of the total individuals who complained of a cough, 27 (90%)
provided semi-sputum/saliva samples. None of the samples
were positive for AFB. However, sputum samples from 2 indi-
viduals with NTM infections who interrupted the treatment
and did not re-start were found to be culture-positive.
A review of TB registers in the two health centers revealed
that there were a total of 117 individuals (86 at Meleka Werer
and 31 at Meleka Sadi health centers, age range 1–80 years,
mean age of 29.6 years) on the DOTS during the survey period.
Of these, 67 (57.3%) were males, 72 (61.5%) were urban/semi-
urban residents, 89 (76.7%) were PTB cases and 28 subjects
had extra-pulmonary TB (EPTB). Out of the 89 PTB cases, 52
(58.4%) were smear positive, of whom 26 were from the study
kebeles.Discussion
Information on the prevalence of TB in different segments of
the population in different settings is vital for the planning,
execution and evaluation of control strategies for the disease
at the local, national and global levels. In this study, a com-
munity-based prevalence of active PTB was assessed in the
pastoral community of the Amibara District of the Afar Re-
gion using a PTB symptoms questionnaire, sputum smear
microscopy, culture and mycobacterial genotyping. A symp-
toms-based questionnaire survey revealed 222 individuals
(1.2% or 1220 per 100,000 population) who were suspected of
having PTB. This prevalence is low when compared with the
prevalence revealed by previous studies from other parts of
Ethiopia [2,4,7,35], and elsewhere [5,36]. The prevalence (22/
100,000 population) of smear-positive PTB cases in the studied
population was comparable to the prevalence reported from
southern parts of Ethiopia [37], but lower than the results of
other studies from the country [2,4,7,38]. Various studies have
demonstrated a relationship between season and TB inci-
dences in various countries [39–41]. The present study was
undertaken during the hot/dry season in the Afar Region.
On the other hand, people usually complain of chronic
coughs during the cold season. This could be one reason for
the low prevalence of symptoms suggestive of PTB in the
present study area.
HIV-infection is also one of the main factors that affect
screening of PTB using clinical symptoms [6]. However, in
the present study, out of the 54 individuals who were positive
for mycobacterial infection by the culture method, and
screened for HIV-infection as per the national TB and HIV
guidelines of Ethiopia [31], only 1 (1.9%) was found to be
seropositive for HIV infection. In addition, according to the
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prevalence of HIV-infection is very low (below 0.01%) in the
pastoral communities of the district (personal communica-
tion). This indicates that the observed low prevalence of
smear positivity in the present study area might not be re-
lated to immune suppression due to HIV infection, but might
be related to low bacterial load.
The WHO highly recommends strengthening the coverage
of culture facilities in TB high-burden countries in order to
achieve the Global Plan of the Stop TB targets as desired by
2015 [41,42]. In the Afar region, there was only one referral
hospital, which was located in Dubti District, about 300 km
from the present study site, while in Amibara District there
were two health centers providing DOTS services. However,
there was no culture facility in the Region. In addition, only
the referral hospital provided functioning radiological ser-
vices during the study periods. Hence, most patients who
have symptoms suggestive of TB and can afford transport/
treatment-related costs prefer to go to other areas, such as
Adama Hospital (Oromia Region), Dessie Hospital (Amhara
Region) or Djibouti (outside Ethiopia), to seek effective diagno-
sis and treatment. In this study, 159 (71.6%) individuals sus-
pected of PTB (of whom 42, 29.6%, were culture-positive for
mycobacterial infection) complained that they did not get
effective diagnosis and treatment for their illness, even
though they visited one or more health facilities in the area.
During this survey, of the 222 study participants with symp-
toms suggestive of active PTB, only 4 individuals (1.8%) were
found to be positive for active PTB using smear microscopy.
However, using the culturemethod, 58 (26.1%) additional indi-
viduals were identified with mycobacterial infection who
would have been undiagnosed if only smear microscopy had
been used. This result supports the findings of studies by
Wood et al. [6] and Tupasi et al. [8] who demonstrated a high
prevalence of active PTB cases by the culturemethod. Sputum
culture is the gold standard for the bacteriological diagnosis
of PTB, and it requires only 10–100 bacteria per ml to detect
PTB in 80–85% of cases with a specificity of approximately
98%, while smear microscopy requires more than 10,000 bac-
teria per ml to detect AFB [43]. Considering the thin sputum
smear that is prepared per slide, the chance of missing the ba-
cilli would be high in case of low bacillary load. Therefore, pri-
ority needs to be given to improving culture laboratory
services, and ensuring accessibility for the pastoral commu-
nities in the present study area.
There is little/no information on the health significance of
NTM and the magnitude of infection in humans in Ethiopia.
In this study, NTM was isolated from sputum samples from
a considerable number of patients (16 out of 39 samples) with
chronic cough (median duration of coughing was 52 weeks),
though it was not possible to identify at the species level ow-
ing to a constraint on laboratory facilities. This detection of
NTM in sputum samples from the study participants could
indicate that infection with NTM may play a significant role
in intensifying the magnitude of TB/lung diseases in the pres-
ent study area. In developing countries, where there are lim-
ited resources and laboratory facilities for the identification of
NTM, infection with NTM can be misdiagnosed as infection
with Mtb complex [24]. For instance, a study of NTM among
HIV-negative South African gold miners showed that morethan 80% of the patients who were suspected of having PTB
were AFB-positive for Mycobacterium kansasii or Mycobacterium
scrofulaceum infections [22]. The present study also implies
that many cases of NTM infection would have been misdiag-
nosed as infection with Mtb if only smear microscopy/culture
had been used. Further studies are needed on the prevalence
and identification of species of NTM, clinical features, meth-
ods of diagnosis, and treatment, as well as the source of infec-
tion and control of the disease in various parts of Ethiopia in
general, and in the present study area in particular. In addi-
tion, adopting the criteria for the diagnosis of NTM and
appropriate treatment which has been established by the
American Thoracic Society [16] as well as increasing aware-
ness of physicians about the health significance of NTM infec-
tion would be important.
Many studies have reported associations between the
prevalence of TB found by active case finding, and gender,
age or distance from the health facility [4,7,8,44], although
they used different screening methods. The results of the
present study showed a high proportion of culture positivity
in the 21–35 year age group, which is consistent with the esti-
mated trend of national prevalence of TB in 2004 [45]. Similar
to the findings of a previous study in Ethiopia [7], the propor-
tion of active case findings was also high in study participants
from kebeles 40 km away from the district health centers. A
previous study on the determinants of conventional health
service utilization among pastoral communities of the Afar
region revealed that distance from the health facility, having
economic problems, and being mobile pastoralists were the
major negative determinants of modern health facility utili-
zation [46]. In agreement with this previous study, a consider-
able number of this study’s participants mentioned that they
did not seek treatment for their illness mainly because of eco-
nomic problems. In addition, most of the study participants
had no idea that the anti-TB drug is free of charge. Thus,
attention should be given to identification and improvement
of factors or systems barriers to accessing TB treatment ser-
vices in the pastoral community of the Afar Region, as recom-
mended by the WHO [1].
Non-adherence to anti-TB treatment is one of the major
challenges in TB control. In the present study, 23 out of 41
(56.1%) patients who started anti-TB drug therapy have re-
ported treatment interruption because of various reasons,
including side effects of the drugs, migration, getting relief
from their illness and distance from the health center. Previ-
ous studies in other parts of Ethiopia also showed a high (20–
43%) treatment interruption in TB patients because of reasons
such as side effects of the drugs and distance from health
centers [47,48]. A study on quality of TB care in selected
health facilities of the present study area also showed poor
staffing qualities, weak patterns of supervision of patients
and dissatisfaction of patients with the adequacy of working
hours and waiting time [49]. Hence, designing a special treat-
ment strategy applicable to the nomadic mode of life, like
involving mobile nomadic community health workers and/
or initiating a TB village approach and appropriate advice
would help TB patients stick to their prescribed treatment
in the present study area as reported from elsewhere [50].
Use of integrated screening methods (questionnaire, chest
radiography, sputum smear microscopy, and sputum culture)
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would maximize the accuracy of determining TB prevalence
in that study population [51]. Because of the lack of chest radi-
ography in the study area, study participants were not
screened using that method, which could be one of the limi-
tations of the present study. Infection with NTM is rising glob-
ally, and playing a significant role in public health problems
among AFB-positive and/or culture-positive patients [24].
However, NTM are ubiquitous organisms, and a hugely di-
verse species [19,52], which could result in false culture posi-
tivity as a result of specimen contamination or colonization.
In the present study, NTM was isolated from sputum samples
from individuals who complained of symptoms suggestive of
PTB for years, but did not get effective diagnosis and treat-
ment. However, because of the lack of laboratory facilities in
Ethiopia, NTM was not genetically characterized at the spe-
cies level, which could be a major weakness of the present
study. Nevertheless, the study provides important prelimin-
ary information on the status of NTM infection in the pastoral
setting where data are rare or not available.
In conclusion, although Ethiopia started to implement the
DOTS strategy in the early 1990s and coverage reached about
95% [6], the findings of the present study revealed that it is
unlikely to meet the Stop TB Strategy of the WHO mainly be-
cause effective diagnostic tools are limited. Hence, expansion
and strengthening of health facility services, and supporting
the DOTS strategy by active case detection, would contribute
to the TB control strategies in Ethiopia in general, and in the
peripheral communities such as pastoralists in particular.
Further investigations into the species identification of the
NTM infection as well as the source of infection would be use-
ful for the appropriate control of NTM infection in the study
area.
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